Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Wave Life Sciences ($WVE) Achieves Groundbreaking Success in RNA Editing for…
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring
Capricor Therapeutics (CAPR) Soars on Promising FDA Discussions: Is This a…
EMCORE (EMKR): A Takeover Target? Mobix Labs’ Bold Bid Shakes Things…
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
CRIS News
Tag: CRIS News
Curis, Inc. (NASDAQ: CRIS) Will Present Data on Its TakeAim Leukaemia...
Gavins Felicity
-
June 14, 2022
0
Curis, Inc. (NASDAQ: CRIS) Recently Announced Its Partners’ Publication on Emarvusatib
Kate Hudson
-
March 15, 2022
0
Curis Inc. (NASDAQ: CRIS) Reports Positive Dose Escalation And Expansion Results...
Kate Hudson
-
January 21, 2022
0
Curis Inc. (NASDAQ: CRIS) Expands Executive Leadership With Addition Of Three...
Gavins Felicity
-
January 13, 2022
0
Curis Inc. (NASDAQ: CRIS) Doses First Subject in The Combination Therapy...
Kate Hudson
-
November 19, 2021
0
Recent Post
Wave Life Sciences ($WVE) Achieves Groundbreaking Success in RNA Editing for...
Gavins Felicity
-
October 16, 2024
0
In a landmark advancement in biotechnology, Wave Life Sciences Ltd. (Nasdaq: WVE), headquartered in Cambridge, Massachusetts, has announced compelling results from its...
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
October 10, 2024
WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring
October 10, 2024
Capricor Therapeutics (CAPR) Soars on Promising FDA Discussions: Is This a...
October 1, 2024
EMCORE (EMKR): A Takeover Target? Mobix Labs’ Bold Bid Shakes Things...
October 1, 2024